Related Experiment Videos
[Latex allergy in patients with spina bifida: prevention and treatment]
J F Martínez-Lage1, M A Moltó, J A Pagán
1Unidad de Neurocirugía Pediátrica, Hospital Universitario Virgen de la Arrixaca, Murcia.
Insights
Latex allergy is a growing concern, especially for children with spina bifida (SB) due to repeated surgeries. Implementing latex-free protocols can effectively prevent allergic reactions in these vulnerable patients.
Area of Science:
- Allergy and Immunology
- Pediatric Surgery
- Neurosurgery
Context:
- Latex allergy presents significant clinical challenges, with prevalence in spina bifida (SB) patients reported between 10% and 73%.
- Children with SB undergo numerous surgeries for associated neurological, orthopedic, and urological issues, increasing latex exposure.
- Risk factors for latex allergy in SB patients include age, cumulative surgical procedures, and potential genetic predispositions.
Purpose:
- To outline preventative strategies for managing latex allergy in pediatric patients with spina bifida.
- To establish hospital protocols for different clinical scenarios involving latex exposure in SB patients.
- To reduce the incidence and severity of latex allergy manifestations in this high-risk population.
Summary:
- Developed hospital protocols to manage three clinical situations for SB patients regarding latex exposure.
- Recommendations include avoiding latex products from birth, preventing latex use in non-allergic post-operative patients, and implementing latex-free environments for allergic patients.
- These preventive measures are practical, cost-effective, and minimally disruptive for healthcare staff.
Impact:
- Successful implementation of these protocols can significantly decrease latex allergy incidence in spina bifida patients.
- Provides a framework for other institutions to adopt similar latex-avoidance strategies.
- Enhances patient safety and quality of care for children with spina bifida undergoing multiple medical interventions.
Abstract:
Latex allergy has become a health problem of growing interest due to the severe clinical manifestations it may produce. Previous reports indicate a prevalence of latex allergy in patients with spina bifida (SB) ranging between 10% and 73%. From the initial surgical repair of the myelomeningocele, children with SB are submitted to multiple surgeries due to the neurologic, orthopedic and urologic problems they may present. Consequently, these children are exposed to several latex-containing products during their multiple interventions. Several reports indicate that latex allergy in SB children is related to age, and especially to the number of operations that they are given, and perhaps to an unknown genetic predisposition. Accordingly, latex allergy manifestations can be prevented. In this connection, we have elaborated at our hospital protocols for the management of the three clinical situations in which these patients can present. These measures include: (1) To avoid using latex-containing products since the birth of children with SB. (2) In children already operated of myelomeningocele but without evidence of latex allergy, to prevent the use of latex materials during their successive admissions to hospital and during further surgeries. And (3) In children known to have developed latex allergy, to dispose of especial nursing measures and of a latex-free operating room. The preventive measures that have been started at our Hospital are easy to carry out, do not suppose a high economic cost, and are not uncomfortable for the hospital's staff.